Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands

Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been p...

Full description

Saved in:
Bibliographic Details
Published inBiochimie Vol. 92; no. 9; pp. 1153 - 1163
Main Authors Tiwari, Rakesh, Brown, Alex, Narramaneni, Seetha, Sun, Gongqin, Parang, Keykavous
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP ( 1, Ac-VSL12, K d = 0.34 μM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [ βAVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity ( K d = 2.19–4.85 μM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] ( 5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity ( K d = 0.35 μM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.
AbstractList Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP ( 1, Ac-VSL12, K d = 0.34 μM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [ βAVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity ( K d = 2.19–4.85 μM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] ( 5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity ( K d = 0.35 μM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.
Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.
Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.
Author Parang, Keykavous
Sun, Gongqin
Tiwari, Rakesh
Brown, Alex
Narramaneni, Seetha
Author_xml – sequence: 1
  givenname: Rakesh
  surname: Tiwari
  fullname: Tiwari, Rakesh
  organization: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 41 Lower College Road, Kingston, RI 02881, USA
– sequence: 2
  givenname: Alex
  surname: Brown
  fullname: Brown, Alex
  organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA
– sequence: 3
  givenname: Seetha
  surname: Narramaneni
  fullname: Narramaneni, Seetha
  organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA
– sequence: 4
  givenname: Gongqin
  surname: Sun
  fullname: Sun, Gongqin
  organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA
– sequence: 5
  givenname: Keykavous
  surname: Parang
  fullname: Parang, Keykavous
  email: kparang@uri.edu
  organization: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 41 Lower College Road, Kingston, RI 02881, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20109515$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtLJDEUhcPgMLbO_INBsnNV7U1XdT1cCCLjAwQXPbMOedy0aVJJmVQL_e8n1a0bFwoXQi7nOzc594Qc-eCRkN8M5gxYfbGZSxvUs50vILeA5Wq-kRmry7aoWVsekRmUAEUHbXVMTlLaAMASFt0Pcjwh3ZItZ2RY7fz4jMkmKrym-CrcVow2eBoMVcGbEPv9XTi3mxppjMJ61HTAYbQaMyZcWG8xGySaregqKrq6L6kOfVZSab22fk2dXecJ6Sf5boRL-OvtPCX_bv_8vbkvHp_uHm6uHwtVQTMWWGGras3QIFQSFtCikYx1ymBb1ZUBZAtkkukOpK6Nyp-UDSt1KRpTGrksT8n5wXeI4SW_buS9TQqdEx7DNvGm6nIcddtk5dmbcit71HyIthdxx99DyoLLg0DFkFJEw5Ud96FMWTjOgE8b4Rt-2Mie5MByTe7VB_jd_wvs6oBhzujVYuRJWfQKtY2oRq6D_dzgP6GyqRY
CitedBy_id crossref_primary_10_1016_j_bmcl_2011_05_010
crossref_primary_10_1016_j_pharmthera_2017_02_014
crossref_primary_10_1016_j_bmc_2012_09_057
crossref_primary_10_1371_journal_pone_0261696
crossref_primary_10_1016_j_bmcl_2011_01_047
crossref_primary_10_1002_cmdc_201600387
crossref_primary_10_1016_j_ejmech_2011_07_050
crossref_primary_10_1186_2008_2231_20_100
ContentType Journal Article
Copyright 2010 Elsevier Masson SAS
Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: 2010 Elsevier Masson SAS
– notice: Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.biochi.2010.01.017
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Anatomy & Physiology
Chemistry
EISSN 1638-6183
EndPage 1163
ExternalDocumentID 20109515
10_1016_j_biochi_2010_01_017
S0300908410000350
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
H~9
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SSU
SSZ
T5K
TWZ
VH1
WUQ
Y6R
ZGI
ZXP
~02
~G-
~KM
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ID FETCH-LOGICAL-c407t-e4e8c6d1efe04b0208efb119cfe8464f0e12e1b1d90bd6fc084b713d3a7f3fb53
IEDL.DBID AIKHN
ISSN 0300-9084
1638-6183
IngestDate Thu Jul 10 18:27:44 EDT 2025
Mon Jul 21 05:38:38 EDT 2025
Thu Apr 24 23:07:00 EDT 2025
Tue Jul 01 00:39:01 EDT 2025
Fri Feb 23 02:29:15 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords SH3 domain
Fluorescence polarization
c-Src
VSL12
Peptide synthesis
Conformationally constrained peptides
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-e4e8c6d1efe04b0208efb119cfe8464f0e12e1b1d90bd6fc084b713d3a7f3fb53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://digitalcommons.chapman.edu/context/pharmacy_articles/article/1151/viewcontent/auto_convert.pdf
PMID 20109515
PQID 749005687
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_749005687
pubmed_primary_20109515
crossref_citationtrail_10_1016_j_biochi_2010_01_017
crossref_primary_10_1016_j_biochi_2010_01_017
elsevier_sciencedirect_doi_10_1016_j_biochi_2010_01_017
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-09-01
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: 2010-09-01
  day: 01
PublicationDecade 2010
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle Biochimie
PublicationTitleAlternate Biochimie
PublicationYear 2010
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Steinauer, White (bib24) 1994
Feng, Kasahara, Rickles, Schreiber (bib14) 1995; 92
Smith, Bartlett (bib18) 1998; 120
Shen, Batzer, Koehler, Polakis, Schlessinger, Lydon, Moran (bib8) 1999; 18
Thomas, Brugge (bib1) 1997; 13
Cao, Tay, Guy, Tan (bib9) 1996; 16
Khan, Parrish, Fraser, Smith, Bartlett, James (bib17) 1998; 37
Feng, Chen, Yu, Simon, Schreiber (bib12) 1994; 266
Lynch, Loiacono, Tiong, Adams, MacNeil (bib23) 1997; 247
Xu, Harrison, Eck (bib4) 1997; 385
Davidson, Lubman, Rose, Waksman, Martin (bib19) 2002; 124
Sicheri, Moarefi, Kuriyan (bib6) 1997; 385
Roskoski (bib7) 2005; 331
Songyang, Shoelson, Chaudhuri (bib5) 1993; 72
Ferguson, Fan, Mukherjee, Luo, Khan, Ferreon, Hilser, Shope, Fox (bib15) 2004; 13
Rickles, Botfield, Xiao-Mai, Henry, Brugge, Zoller (bib13) 1995; 92
Szewczuk, Stefanowicz, Wilczynski, Staszewska, Siemion, Zimecki, Wieczorek (bib20) 2004; 74
Warmuth, Damoiseaux, Liu, Fabbro, Gray (bib2) 2003; 9
Donaldson, Dempsey, Reddy, Bouton, Coffey, Hanks (bib10) 2000; 256
Ngugen-Hai, Ye, Sun, Parang (bib21) 2004; 47
Kumar, Ye, Wang, Lin, Sun, Parang (bib22) 2006; 49
Pawson (bib3) 1995; 373
Yu, Chen, Feng, Dalgarno, Brauer, Schreiber (bib11) 1994; 76
Humphrey, Chamberlin (bib16) 1997; 97
References_xml – volume: 266
  start-page: 1241
  year: 1994
  end-page: 1247
  ident: bib12
  article-title: Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3–ligand interactions
  publication-title: Science
– volume: 385
  start-page: 595
  year: 1997
  end-page: 602
  ident: bib4
  article-title: Three dimensional structure of the tyrosine kinase c-Src
  publication-title: Nature
– start-page: 689
  year: 1994
  end-page: 692
  ident: bib24
  article-title: Innovations and perspectives in solid phase synthesis
  publication-title: 3rd International Symposium
– volume: 385
  start-page: 602
  year: 1997
  end-page: 609
  ident: bib6
  article-title: Crystal structure of the Src-family tyrosine kinase Hck
  publication-title: Nature
– volume: 120
  start-page: 4622
  year: 1998
  end-page: 4628
  ident: bib18
  article-title: Macrocyclic inhibitors of penicillopepsin. 3. Design, synthesis, and evaluation of an inhibitor bridged between P2 and P1
  publication-title: J. Am. Chem. Soc.
– volume: 92
  start-page: 10909
  year: 1995
  end-page: 10913
  ident: bib13
  article-title: Phage display selection of ligand residues important for Src Homology 3 domain binding specificity
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 16
  start-page: 1595
  year: 1996
  end-page: 1603
  ident: bib9
  article-title: Activation and association of Stat3 with Src in v-Src-transformed cell lines
  publication-title: Mol. Cell. Biol.
– volume: 13
  start-page: 513
  year: 1997
  end-page: 609
  ident: bib1
  article-title: Cellular functions regulated by Src family Kinase
  publication-title: Annu. Rev. Cell Dev. Biol.
– volume: 18
  start-page: 4647
  year: 1999
  end-page: 4653
  ident: bib8
  article-title: Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src
  publication-title: Oncogene
– volume: 9
  start-page: 2043
  year: 2003
  end-page: 2059
  ident: bib2
  article-title: Src family kinases potential targets for the treatment of human cancer and leukemia
  publication-title: Curr. Pharm. Des.
– volume: 74
  start-page: 352
  year: 2004
  end-page: 362
  ident: bib20
  article-title: Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence
  publication-title: Biopolymers
– volume: 97
  start-page: 2243
  year: 1997
  end-page: 2266
  ident: bib16
  article-title: Chemical synthesis of natural product peptides: coupling methods for the incorporation of noncoded amino acids into peptides
  publication-title: Chem. Rev.
– volume: 72
  start-page: 767
  year: 1993
  end-page: 778
  ident: bib5
  article-title: SH2 domains recognize specific phosphopeptide sequences
  publication-title: Cell
– volume: 13
  start-page: 626
  year: 2004
  end-page: 632
  ident: bib15
  article-title: Directed discovery of bivalent peptide ligands to an SH3 domain
  publication-title: Protein Sci.
– volume: 331
  start-page: 1
  year: 2005
  end-page: 14
  ident: bib7
  article-title: Src kinase regulation by phosphorylation and dephosphorylation
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 256
  start-page: 168
  year: 2000
  end-page: 178
  ident: bib10
  article-title: Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell–cell contacts of polarized epithelial cells
  publication-title: Exp. Cell Res.
– volume: 124
  start-page: 205
  year: 2002
  end-page: 215
  ident: bib19
  article-title: Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding
  publication-title: J. Am. Chem. Soc.
– volume: 76
  start-page: 933
  year: 1994
  end-page: 945
  ident: bib11
  article-title: Structural basis for the binding of proline-rich peptides to SH3 domains
  publication-title: Cell
– volume: 92
  start-page: 12408
  year: 1995
  end-page: 12415
  ident: bib14
  article-title: Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 247
  start-page: 77
  year: 1997
  end-page: 82
  ident: bib23
  article-title: A fluorescence polarization based Src-SH2 binding assay
  publication-title: Anal. Biochem.
– volume: 49
  start-page: 3395
  year: 2006
  end-page: 3401
  ident: bib22
  article-title: Synthesis and structure–activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitor
  publication-title: J. Med. Chem.
– volume: 37
  start-page: 16839
  year: 1998
  end-page: 16845
  ident: bib17
  article-title: Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes
  publication-title: Biochemistry
– volume: 373
  start-page: 573
  year: 1995
  end-page: 580
  ident: bib3
  article-title: Protein modules and signalling networks
  publication-title: Nature
– volume: 47
  start-page: 3131
  year: 2004
  end-page: 3141
  ident: bib21
  article-title: Conformationally constrained peptide analogues of pTyr–Glu–Glu–IIe as inhibitor of the Src SH2 domain binding
  publication-title: J. Med. Chem.
SSID ssj0005029
Score 2.0135279
Snippet Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1153
SubjectTerms c-Src
Conformationally constrained peptides
Electrophoresis, Polyacrylamide Gel
Fluorescence Polarization
Ligands
Molecular Structure
Peptide synthesis
Peptides - chemical synthesis
Peptides - chemistry
Protein Binding
SH3 domain
src Homology Domains
VSL12
Title Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands
URI https://dx.doi.org/10.1016/j.biochi.2010.01.017
https://www.ncbi.nlm.nih.gov/pubmed/20109515
https://www.proquest.com/docview/749005687
Volume 92
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa69tDtMKzpHt26QodhNzeWrdjyMQhWZC3aS1agN8GSqM1Dagd1eshlv32UbKfroSgwQCeBlGWRlkj5IwnwJSMTItP--y7zPBLkKEcyM0mkhaWtEdOSSx-NfHmVza_F-c3kZgdmQyyMh1X2e3-3p4fduu8Z96s5XlXVeEHqGRexFOGGOvV--16SFhmp9t70-8X86gHpEYdiZZ4-8gxDBF2AeemqMb-qHuPFqeVPnVBPWaDhJDp7A697E5JNu1kewA7WIzic1uQ-327YVxZAneG2fAT7s6Gg2whe_ZN78BBWi01Nxl9btaysLXvI-s0ax8hJ3kY1lsvlxne0oZoEWrbyQBiLxNZd_NAALaOh2OLOsMU8Zba5JUqmqxAxw5bVTx9P_Bauz779mM2jvvxCZMjLW0coUJrMcnQYC-2LeaLTnBfGIRktwsXIE-Sa2yLWNnOGVlaTy2tJ6i51epK-g926qfEDsMzk0iaYWi1RTKSVpXQmEWUhnRWyjI8gHZZcmT43uX-ppRpAaL9VJyjlBaViTi0_gmjLtepyczxDnw_SVI90TNHx8QwnG4SvSGj-n0pZY3PfqlwUPpuqJJL3nVJsp-L5yX6dfPzvx36Clx1YwUPajmF3fXePn8kGWusTeHH6h5_0mv4XScMG4w
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwEB0hegAOVbvQllJaHypuYeONN3GOaFW0bYHLgsTNiu1xG7QkK7Ic9tJvZ-wkWzggJKScrBnH8YztGefNDMD3lEyIVPv1XWRZJMhRjmRqRpEWlrZGTAoufTTy-UU6vRK_rsfXGzDpY2E8rLLb-9s9PezWXcuwm83hoiyHM1LPOI-lCDfUiffb3whavn51Hv97hPOIQ6kyTx158j5-LoC8dFmbv2WH8OL0ZM-dT8_Zn-EcOn0HbzsDkp20Y3wPG1gNYPekIuf5dsWOWIB0hrvyAWxN-nJuA9h5lHlwFxazVUWmX1M2rKgs-5_zm9WOkYu8jmks5vOVb2hCLQm0bOFhMBaJrb32oQ4aRl2x2Z1hs2nCbH1LlEyXIV6Gzcs_Ppp4D65Of1xOplFXfCEy5OMtIxQoTWo5OoyF9qU80WnOc-OQTBbhYuQj5JrbPNY2dYZmVpPDa0nmLnF6nHyAzaqu8BOw1GTSjjCxWqIYSysL6cxIFLl0Vsgi3oekn3Jluszk_qPmqoeg3ahWUMoLSsWcnmwfojXXos3M8QJ91ktTPdEwRYfHC5ysF74iofk_KkWF9X2jMpH7XKqSSD62SrEeiucn63X8-dWv_QZb08vzM3X28-L3AWy3sAUPbvsCm8u7ezwka2ipvwZtfwBz2Aen
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+evaluation+of+conformationally+constrained+peptide+analogues+as+the+Src+SH3+domain+binding+ligands&rft.jtitle=Biochimie&rft.au=Tiwari%2C+Rakesh&rft.au=Brown%2C+Alex&rft.au=Narramaneni%2C+Seetha&rft.au=Sun%2C+Gongqin&rft.date=2010-09-01&rft.pub=Elsevier+Masson+SAS&rft.issn=0300-9084&rft.eissn=1638-6183&rft.volume=92&rft.issue=9&rft.spage=1153&rft.epage=1163&rft_id=info:doi/10.1016%2Fj.biochi.2010.01.017&rft.externalDocID=S0300908410000350
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9084&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9084&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9084&client=summon